Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Complix raises €12mm through Series B round

Executive Summary

Complix NV (protein therapeutics for cancer and autoimmune diseases) raised €12mm ($15.5mm) through its Series B round co-led by new investors Edmond de Rothschild Investment Partners, GIMV, and Biotech Fund Flanders (managed by GIMV). LRM, Omnes Capital, Vesalius Biocapital, Gemma Frisius Fund, TrustCapital, Vinnof, Baekeland Fund, CRP-Santé, and members of Complix’s management also participated. One executive from Edmond de Rothschild and GIMV will join the company's board.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies